[ad_1] An inexpensive FDA-approved drug, cholestyramine, taken in combination with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team’s findings appear today (December 1) in the journal eLife. “Antimicrobial resistance is a serious problem …
Read More »A new combination therapy can help fight antimicrobial resistance
